Avid Bioservices (CDMO) Misses Q4 EPS by 1c; guides below views

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. CRGY
5. RMR
6. GOOG
7. SPY
8. ANGO
9. LULU
10. PEP

Go back to Avid Bioservices (CDMO) Misses Q4 EPS by 1c; guides below views

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2023

June 21, 2023 4:07 PM EDT

-- Fourth Quarter and Full Year Revenue of $39.8 Million and $149.3 Million, Respectively, Both Represent a Record-High Achievement --

-- Signed $55 Million in Net New Business Orders Resulting in a Record-High Backlog of $191 Million --

-- Mammalian Cell Manufacturing and Process Development Facility Expansions Currently Online and Active, Adding Approximately $120 Million of Annual Revenue Generating Capacity --

-- Cell and Gene Therapy Facility Expansion Remains on Schedule; Expected to be Online by End of Calendar Q3 2023 --

-- FY 2024 Revenue Guidance of Between... More